Filter
914
Text search:
formulations
Featured
131
248
Language
Document type
449
222
116
56
19
19
12
10
4
3
2
1
Countries / Regions
54
40
28
20
19
17
15
14
12
12
11
11
10
9
9
9
9
8
8
8
7
7
7
7
7
7
6
6
5
5
4
4
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
304
143
61
61
39
15
15
Toolboxes
94
88
68
60
54
44
43
24
21
21
14
13
10
10
10
8
7
7
7
7
5
4
4
2
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
Q3: Are pharmacotherapies safe and effective for the treatment of psychostimulant dependence (maintenance or relapse prevention) in non-specialized settings?
Diphtheria in the Americas -Summary of the situation.
In 2018, three countries in the Region of the Americas (Colombia, Haiti, and the Bolivarian Republic of Venezuela) reported confirmed cases of diphtheria. In 2019, Haiti and Venezuela reported confirmed cases.
Introduction
Chapter A.7
Other disorders
Chapter H.3
Other disorders
Chapter H.5.1
Externalizing disorders
Chapter D.1
Attention deficit hyperactivity disorder
Published: February 23, 2010
https://doi.org/10.1371/journal.pmed.1000235
Volume 7 | Issue 2 | e1000235
The steps are presented in a user-friendly guidebook, designed to be a working resource for implementers and leads in infection control, safety, and quality.
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adherence than placebo/treatment as usual?
Implications and Actions
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance who release
...
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
